| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.01 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |